One of the top firms in the US and globally for venture capital deals
Our lawyers have a long track record of partnering with high growth companies and the investors powering the innovation, on their journey from idea to exit. We have a deep understanding for the passion, grit and flexibility entrepreneurs require from their partners to be successful.
We have been in the emerging company and venture capital industry since its inception. It is a core part of who we are as a firm and wasn’t something we jumped on recently as an opportunity to grow our client base. Our team has spent their careers counseling companies and funds on issues like company formation, fund formation, organizational structure, inter-founder matters, private financings and general corporate governance.
We often hear that our clients view us as an extension of their team, and we think that is what truly sets us apart. We seek to build long-term relationships with our clients, and strive to achieve a high degree of familiarity with our client’s technology, position on deals, culture, style and as a result, we offer guidance that is tactical and forward-thinking.
We also have a deep understanding for the industries our clients operate in. Many members of our team have advanced degrees and previous careers as in-house counsel at the types of companies turning to us for support. We are sought out experts in the areas of technology, life sciences, cannabis and energy.
Over the years, we have learned that our clients value not only our tactical and forward-thinking guidance but also our vast network. We often leverage our extensive contacts to make key introductions and provide intelligence on “how the other side thinks.”
Areas of Focus
Our work encompasses support for the full life cycle of startups from idea to exit, as well as the needs of the investors powering innovation.
Beyond transactional support, we frequently act as outside general counsel to our emerging company clients and serve as an extension of their team.
Company Formation
Choice of entity
Tax planning
Succession planning
Private Financings
Angel and seed-round financings
Early, growth, cross-over and late stage venture capital financings
Bridge loans, convertible debt
PIPEs
General Corporate and Board Counseling Support
Corporate governance
Board of director set up and guidance
Employment counseling
Customer and vendor contracts and agreements
IP support - Privacy policy, copy right and trademark review, etc.
Genialis, a computational precision medicine company, in its $13M Series A financing to expand its machine learning platform for clinical and translational research
BostonGene, a developer of biomedical software for advanced patient analysis and personalized therapy, in connection with its $150 million Series B financing that propelled the company to unicorn status (valuation $1 billion+)
Form Health, a leading provider of science-based obesity care, in its $38 million Series B financing round led by Sound Ventures
Toposware, a zero-knowledge-focused blockchain research and engineering firm, in its sale to Polygon Labs
Jana Care, developer of a mobile diagnostic platform designed for diabetes diagnosis and treatment, in connection with its $14.4 million Series B financing
Cruisebound, an online travel site in its $10 million Series A funding, led by former Booking Holdings chairman and Priceline CEO Jeff Boyd and PAR Capital Ventures, with participation from Tripadvisor founder and former CEO Steve Kaufer, Concur founder and Madrona Venture Group managing partner Steve Singh, Link Ventures founder Dave Blundin, Plug & Play Ventures and several others
AeroSafe Global, provider of outsourced cold chain management services intended to serve the pharmaceutical, biopharmaceutical, specialty pharmacy and medical device companies, it the $4 million second closing of its Series F financing round, which was led by NewSpring
Icelandic Provisions, a yogurt producer, in its $29.2 million Series C financing
Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, in a $21.5 million Series B financing
Bespoke Post, a multi-category e-commerce retailer, in its $40 million Series B funding round led by NewSpring
SparkCharge, the world's first mobile EV charging network, in a $23 million Series A funding co-led by Tale Venture Partners and Pendulum
TrialJectory, operator of an AI-based healthcare platform designed to connect cancer patients with clinical trials, in its $20 million Series B financing, led by Insight Venture Management
Solo.io, a developer of tools to help the enterprise adapt and make the most of innovative cloud technologies in their $135 million Series C financing led by Altimeter, which pushed the company into the “unicorn club” by meeting $1 billion+ valuation mark
LinearB, a developer of productivity analytics software, in its $50 million Series B Financing round, led by Tribe Capital
Zapata Computing, a high-growth quantum software company in multiple financing rounds, including:
its $38 million Series B financing, led by Comcast Ventures, Pitango and Prelude Ventures
$21 million Series A financing
Alcyone Therapeutics in relation to a $23.0 million financing led by funds affiliated with RTW Investments, LP., to support its pioneering development of next-generation precision central nervous system therapies
BostonGene, a developer of biomedical software for advanced patient analysis and personalized therapy, in connection with its $150 million Series B financing, which resulted in the company gaining “unicorn” status
Alloy Therapeutics as an investor in several matters and its own fundraising efforts, including the following:
its $42 million Series D financing round led by its existing investors 8VC and Mubadala Capital
its $75.0 million Series C Financing led by 8VC, Presight Capital and Peter Thiel
with the formation of Broadwing Bio LLC, a joint venture with Maze Therapeutics, Inc., to develop targeted antibody therapies for the treatment of ophthalmic diseases
as an investor in its $21 million Series A Preferred Stock Financing of Vernal Biosciences, a manufacturer of high purity mRNA for research and clinical use
Shift5, the OT cybersecurity company that defends military platforms and critical transportation systems from cyberattacks, in multiple financing rounds, including its $50 million in a Series B round led by Insight Partners
PhotoShelter, a provider of digital asset management software for organizations and creative professionals, in a $47 Million growth investment from Clearhaven Partners
Form Health, a telemedical weight loss company, in its $12 million Series A funding led by M13, with participation from SignalFire and NextView Ventures
Satellite Bio, a regenerative medicine company, in raising $110 million in Seed and Series A funding
RedShift BioAnalytics Inc. (RedShiftBio), a company providing next-generation platform technology enabling measurement of previously undetectable structure changes in biomolecules, in the closing of its $20 million Series E Preferred Stock financing
Rental platform Zumper in multiple financing rounds, including:
a $60 million Series D round led by e.ventures
$46 million Series C financing
$17.6 million Series B funding led by Breyer Capital and Foxhaven Asset Management, including follow-up funding from existing investors
ezCater, the only nationwide marketplace for business catering, in multiple financings, including its $100 million Series D financing led by Wellington Management Company LLP, with participation from existing investors ICONIQ Capital, Insight Venture Partners and others
INVESTOR REPRESENTATION
H.I.G. BioHealth Partners and Accelmed Partners as new investors and co-leads in the $52 million upsized Series B financing of digital therapeutics company Click Therapeutics, Inc. (“Click”)
Endicott Growth Equity Partners, L.P. (EGEP), an investment fund focused exclusively on the information services, data, and analytics sector, in the acquisition of a majority stake and strategic growth investment in BNamericas, a market-leading data and analysis company that provides critical business insights and actionable industrial project data on key sectors in Latin America
Bessemer Venture Partners in multiple financings, including as lead investor in the Series C financing of smart water dispenser Bevi (Hydration Labs) and as lead investor in a $17 million funding round for money management platform Truebill, Inc.
Early stage venture capital firm .406 Ventures in multiple investments, including in its $9 million Series A investment in log search and analytics platform CHAOSSEARCH
Venture capital firm CRV in multiple financings, including as lead investor in a $10 million Series A for contract management company Concord
Prime Impact Fund as lead investor in Clean Crop Technologies, Inc. Series Seed Financing
Events
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
